![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 48, 44785-44791, November 30, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Centro de Biología Molecular "Severo Ochoa," Departamento de Biología Molecular, Facultad de Ciencias, Universidad Autónoma de Madrid, E-28049 Madrid, Spain
Received for publication, August 2, 2001, and in revised form, September 25, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Red blood cell protein 4.1 (4.1R) is an 80-kDa
protein that stabilizes the spectrin-actin network and anchors it to
the plasma membrane. To contribute to the characterization of
functional roles and partners of specific nonerythroid 4.1R isoforms,
we analyzed 4.1R in human T cells and found that endogenous 4.1R was
distributed to the microtubule network. Transfection experiments of T
cell 4.1R cDNAs in conjunction with confocal microscopy analysis revealed the colocalization of exogenous 4.1R isoforms with the tubulin
skeleton. Biochemical analyses using Taxol®
(paclitaxel)-polymerized microtubules from stably transfected T cells
confirmed the association of the exogenous 4.1R proteins with
microtubules. Consistent with this, endogenous 4.1R immunoreactive proteins were also detected in the microtubule-containing fraction. In vitro binding assays using glutathione
S-transferase-4.1R fusion proteins showed that a
constitutive domain of the 4.1R molecule, one that is therefore present
in all 4.1R isoforms, is responsible for the association with tubulin.
A 22-amino acid sequence comprised in this domain and containing
heptad repeats of leucine residues was essential for tubulin binding.
Furthermore, ectopic expression of 4.1R in COS-7 cells provoked
microtubule disorganization. Our results suggest an involvement of 4.1R
in interphase microtubule architecture and support the
hypothesis that some 4.1R functional activities are cell
type-regulated.
Red blood cell protein 4.1, 4.1R or 4.1R80, was
identified as an 80-kDa multifunctional protein of the membrane
skeleton of human erythrocytes. In these cells, protein 4.1R stabilizes
the spectrin-actin network and anchors it to the overlying lipid
bilayer through interactions with cytoplasmic domains of transmembrane proteins (reviewed in Ref. 1). The formation of the spectrin-actin-4.1R ternary complex is essential for the maintenance of normal erythrocyte morphology and membrane mechanical strength, as alterations in the
spectrin-actin binding site of 4.1R, located at the COOH-terminal region of the molecule (2-5) are associated with congenital hemolytic anemias (6). Protein 4.1R also plays an important role in regulating the glycophorin C-4.1R-p55 ternary complex in the erythrocyte membrane
(7).
Many immunological studies have shown that 4.1R protein is more complex
in nonerythroid cells. Thus, 4.1R-immunoreactive polypeptides ranging
in size from 30 to 210 kDa have been detected in different tissue and
cell types (8, 9) and 4.1R epitopes have been observed at many
different sites, including stress fibers (10), centrosomes (11), and
the nucleus (12-15). The nuclear localization of specific isoforms of
4.1R has recently been confirmed by transfection experiments of 4.1R
cDNAs isolated from erythroid (16) and nonerythroid human cells
(17-19).
The prototypical erythroid protein 4.1R80 is, therefore,
only one of many isoforms that are generated by a single gene, mainly by extensive alternative splicing of the 4.1R pre-mRNA (20-23). 4.1R80 protein is produced when 17 nucleotides 5'-upstream
from exon 2 are spliced out, and translation is initiated at the
downstream start site present in exon 4 (ATG2). The synthesis of
isoforms, termed 4.1R135, containing up to 209 amino acids
to the NH2 terminus of erythroid 4.1R80, occurs
when the 17-nucleotide sequence containing the upstream ATG (ATG1)
translation initiation codon is included. These isoforms are
predominantly expressed in nonerythroid cells (20, 21). A third type of
isoforms, termed 4.1R60, can be produced in erythroid and
nonerythroid cells when both the 17-nucleotide sequence (containing the
ATG1) and exon 4 (containing the ATG2) are spliced out, and translation
is initiated from a third translation initiation site (ATG3) present in
exon 8 (16, 18).
Although the major functions of 4.1R80 protein have been
extensively characterized in mature erythrocytes, the potential roles of 4.1R isoforms in nucleated cells have only begun to be
characterized. It has been reported that 4.1R protein interacts with
various splicing factors (15, 24); with pICln (25), an integral chloride channel component which was recently shown to associate also
with spliceosomal proteins (26); with a novel centrosomal protein,
termed CPAP (27); and with the nuclear mitotic apparatus protein (17).
All of these observations indicate that, in nucleated cells, isoforms
of 4.1R protein may play roles in organizing the nuclear architecture
and mitotic spindle poles. These roles were not suspected from the
initial studies, given that they were performed in anucleate,
nondividing, human red blood cells. Interactions of 4.1R with other
proteins have also been reported (28-34), thus suggesting that 4.1R
protein may be involved in many different events in nucleated cells.
In an attempt to characterize further the functional roles and partners
of nonerythroid 4.1R isoforms, we have analyzed 4.1R distribution in
human T cells and observed that both endogenous and exogenous 4.1R
proteins colocalized with the microtubule skeleton. In vivo
and in vitro biochemical analyses confirmed an association between 4.1R and microtubules. We have determined that a region conserved in all 4.1R isoforms, previously designated by us as the
"core region" (18), was involved in tubulin binding and that 22 amino acids containing leucine residues, organized as heptad repeats,
were essential for the interaction. Our results indicate that both
ATG1- and ATG2-translated 4.1R isoforms are able to associate with
microtubules in interphase human T cells, suggesting the involvement of
4.1R in the microtubule architecture. The finding that ectopic
expression of 4.1R in COS-7 cells resulted in disorganization of the
microtubule architecture supports the hypothesis that the functional
activity of protein 4.1R depends on the cell type in which the protein
is expressed.
Cell Culture and Transfection--
The cell lines used in
this study were human T lymphoid Jurkat and CEM cells and fibroblastic
COS-7 cells. Jurkat and CEM cells were grown in tissue culture flasks
in RPMI 1640 medium (Life Technologies, Inc.). COS-7 cells were grown
on culture dishes or on glass coverslips in Dulbecco's modified
Eagle's medium (Life Technologies, Inc.). Both media were supplemented
with 1% glutamine, 10% (v/v) fetal calf serum (Life Technologies,
Inc.), penicillin (50 units/ml), and streptomycin (50 units/ml).
Cultures were maintained at 37 °C under a 5% CO2, 95%
air humidified atmosphere. Transfection experiments were performed by
electroporation using the Electro Cell Manipulator 600 (8BTX, San
Diego, CA). Cells were processed 48 h after transfection. The 4.1R
cDNAs used for transfections (pSR Recombinant
Proteins--
GST1-4.1R80 Antibodies--
Anti-c-Myc monoclonal antibody 9E10 (37) was
obtained from the American Type Culture Collection. Anti-4.1R (10b)
antibody was an affinity-purified polyclonal antibody generated as
described previously (2). Anti-4.1R (762) was a polyclonal antibody
raised against a synthetic peptide whose sequence is encoded by exon 2 (35). The anti-centrosome antibody was a human autoimmune serum that
strongly recognizes centrosomes in mammalian cells (38).
Anti- Immunofluorescence and Confocal Microscopy--
Human T cells
were incubated in flat-bottomed, 24-well plates in a final volume of
500 µl of complete medium on glass coverslips coated with polylysine
at 1 mg/ml. Cells were fixed, permeabilized, and blocked as described
(19). Cells were incubated with the appropriate antibodies and
processed as reported (13). As 9E10 and DM1A are both mouse monoclonal
antibodies, in Figs. 3 and 8 antibody 10b was used 25-fold diluted,
relative to concentrations used for detection of endogenous protein, to
detect only exogenous epitope-tagged 4.1R proteins (19). In Fig.
2B cells were fixed and extracted at the same time with 5%
formalin (37% formaldehyde solution, Sigma) and 0.5% Triton X-100 in
phosphate-buffered saline for 3 min at room temperature. Images were
obtained using a Bio-Rad Radiance 2000 confocal laser microscope or a
Zeiss epifluorescence microscope.
Protein Extractions and Western Blotting--
Human T cells were
washed twice with phosphate-buffered saline and lysed in Laemmli
solubilizing buffer (39). For immunoblot analysis, protein fractions
were separated by SDS-polyacrylamide gel electrophoresis and
transferred to Immobilon polyvinylidene difluoride (Millipore) in Tris
borate buffer, pH 8.2. Membranes were processed and developed as
described (13).
Isolation of Human T Cell Microtubules--
CEM cells were
harvested by centrifugation and then resuspended in 1/10 of buffer A
(0.1 M MES, 0.5 mM MgCl2, 2 mM EGTA) containing 10 µg/ml pepstatin, leupeptin,
aprotinin, and 1 mM phenylmethylsulfonyl fluoride. Cells
were lysed in 4 °C hypotonic buffer by 25 passages through a
22G1-gauge needle fitted onto a plastic syringe. 10× buffer A was
added to the extract to obtain isotonic buffer A. The lysate was
centrifuged at high speed in a minicentrifuge at 4 °C and processed
as described (40). Briefly, the pellet was discarded and the
supernatant was centrifuged at 100,000 × g for 60 min
at 4 °C in a Beckman TL-100 Tabletop Ultracentrifuge using a
TLA-100.1 fixed-angle rotor. The pellet, corresponding to the membrane-containing fraction, was discarded. The supernatant was supplemented with 10 µM Taxol and 0.1 mM GTP
and incubated for 35 min at 37 °C. Microtubules were centrifuged
through a 15% sucrose cushion in buffer A containing 5 µM Taxol (30,000 × g, 35 min, 37 °C).
The microtubule pellets and supernatants were boiled in Laemmli buffer
and analyzed by Western blotting with 9E10, 10b, or 762 antibodies.
In Vitro Microtubule Binding--
PC-tubulin from bovine brain
(41) was polymerized as described (36), mixed with recombinant proteins
in buffer BRB80 (80 mM K-Pipes, pH 6.8, 1 mM
EGTA, 1 mM MgCl2) containing 10 µM Taxol, and incubated for 15 min at room temperature.
The samples were centrifuged through a 15% sucrose cushion in BRB80,
as described previously (36). Equivalent aliquots of supernatants and
pellets were analyzed on Coomassie-stained gels and Western blots
probed with anti-GST antibody.
Immunolocalization of Endogenous 4.1R Proteins in Human T
Cells--
To understand how 4.1R is distributed in human T cells, we
analyzed CEM cells, fixed in the absence (Fig. 2A) or in the
presence (Fig. 2B) of Triton X-100, by confocal microscopy.
Fig. 2A (a) shows a representative image of cells
stained with the anti-4.1R 10b antibody. Diffuse cytoplasmic staining,
which was more concentrated at the pericentrosomal region, and staining
of both discrete cytoplasmic filaments and the plasma membrane were
observed. Nuclear staining (not shown in this confocal plane) was also
detected. The cytoplasmic filaments decorated with antibody 10b
corresponded to microtubules, as revealed by the anti-tubulin DM1A
antibody (Fig. 2A, b). Microtubules were also
decorated with the anti-4.1R 762 antibody, which recognizes the extra
amino-terminal region of 4.1R135 isoforms (35) (Fig.
2A, c and d). These results indicated
that the microtubule network of human T cells contains 4.1R epitopes.
The 4.1R staining pattern of CEM cells fixed in the presence of Triton
X-100 is shown in Fig. 2B. The Triton X-100 treatment resulted in the extraction of most of the 4.1R immunoreactivity; however, nuclear speckles and a bright spot in the pericentrosomal region were clearly observed in cells stained with the 10b antibody (Fig. 2B, a). The bright spot was stained with
antibodies that recognize the centrosome (Fig. 2B,
b). Antibody 762 did not stain the centrosome (Fig.
2B, c). These results show that centrosomal 4.1R
immunoreactivity is better detected when cells are fixed in the
presence of Triton X-100.
Colocalization of Exogenously Expressed 4.1R Isoforms with
Microtubules of Human T Cells--
To identify specific 4.1R isoforms
that colocalize with microtubules, we transfected T cells with
different 4.1R cDNAs previously isolated by us from human T cells
(18, 35) and compared the intracellular distribution of the expressed
4.1R proteins and that of tubulin by confocal microscopy. Two of the
4.1R cDNAs (4.1R80 Endogenous and Exogenous 4.1R Proteins Cosedimented with
Taxol-polymerized Microtubules Isolated from Human T Cells--
To
determine whether 4.1R and microtubules interacted in vivo,
we performed biochemical assays using T cells stably transfected with
either 4.1R135
Expression of 4.1R135
Duplicates of the microtubule pellet shown in Fig. 4B
(lane 1) were revealed with anti-4.1R antibodies to analyze
endogenous 4.1R proteins cosedimenting in the microtubule pellet (Fig.
4C). Antibody 10b (Fig. 4C, 10b)
detected major bands of ~80 and 145 kDa. Antibody 762 (Fig.
4C, 762) reacted with a 145-kDa band. These
results and those obtained for the exogenously expressed 4.1R isoforms
indicate that both ATG1- and ATG2-translated 4.1R isoforms cosediment
with microtubules.
The Core Region of Protein 4.1R Is Responsible for Tubulin
Binding--
To investigate whether 4.1R80
To identify the 4.1R80
A GST fusion protein containing the core region (GST-core) was assayed
for its tubulin binding ability. Fig.
6A shows the Coomassie-stained
gel of the pellet and the supernatant fractions and Fig. 6B
the Western blot revealed with anti-GST antibody. Protein GST-core was
present in the pellet with tubulin (Fig. 6, A and
B, lanes 3) and absent in the supernatant (Fig.
6, A and B, lanes 6). The fusion
proteins GST-4.1R80 Twenty-two Amino Acids in the 4.1R Core Region Are Required for
Tubulin Interaction--
Primary sequence analysis of the core region
revealed that the NH2-terminal region of exon 10-encoded
sequences comprised heptad repeats of leucine residues resembling a
putative leucine zipper motif (Fig.
7A). To investigate whether
this characteristic sequence was involved in tubulin association, we
created a deletion mutant, termed core- Exogenous Expression of 4.1R80 The great diversity of 4.1R isoforms present in nonerythroid cells
makes it necessary to assay individual isoforms to specifically assign
them cellular functions. In recent years, much effort has been
concentrated on isolating 4.1R cDNAs from different cell sources
for use in the assignment of roles and partners for specific 4.1R
isoforms. In this study we show that naturally occurring exogenously
expressed ATG1- and ATG2-translated 4.1R isoforms, and also endogenous
4.1R proteins, colocalize with the tubulin cytoskeleton of interphase
human T cells. Cosedimentation of 4.1R proteins with microtubules of
human T cells and direct in vitro binding to tubulin
revealed that a common region present in all 4.1R isoforms, the core
region, is responsible for the association of 4.1R with tubulin. This
is the first demonstration of an association between 4.1R and
interphase microtubules.
It is of particular note that the 22-amino acid sequence required for
4.1R-tubulin interaction contains heptad repeats of leucine resembling
leucine zippers (see Fig. 7A) but, unlike the latter, it
does not adopt an Ezrin-radixin-moesin (ERM) proteins belong to the "4.1R protein
family" and are thought to link actin filaments to the plasma membrane at cortical foci (45). Ezrin has also been isolated from
microtubule-associated protein preparations from Madin-Darby canine
kidney and A72 cells and the ERM protein merlin contains a
"cryptic" microtubule binding site exposed specifically in the activated or "open" ERM conformation (reviewed in Ref. 45). Thus,
it has been suggested that some ERM proteins may play an additional
role in linking microtubules to the cell cortex, thus having the
capacity to associate with the microtubule and actin cytoskeletons. One
of the major functions of erythroid 4.1R is the stabilization of the
spectrin-actin complex through the 10-kDa domain (2-5) encoded by
exons 16 and 17. We may speculate that, in nonerythroid cells, 4.1R
isoforms expressing the alternative exon 16 would have the capacity to
bind to the actin and the microtubule cytoskeletons, whereas those 4.1R
isoforms lacking exon 16 expression would only retain the ability to
bind to the microtubule cytoskeleton.
It has been indicated that nonerythroid 4.1R isoforms may have
different functional activities, depending on the cell type in which
they are expressed (31). Thus, 4.1R interacts through its
spectrin-actin binding domain with a protein complex in skeletal muscle
(34) that differs from that described in PC12 cells (31), even though
the latter type of cell also contains the proteins to which 4.1R binds
in skeletal muscle. Concomitantly, we show in this study that
transfection of T cells with T cell-4.1R cDNAs resulted in
overexpression of 4.1R isoforms colocalizing with the microtubule
network, whereas ectopic expression of 4.1R isoforms in COS-7 cells did
not result in 4.1R binding to the microtubules but instead in the
disruption of the microtubule architecture. It is evident, therefore,
that different cell types respond in distinct manners to the expression
of 4.1R, supporting the hypothesis that some functional activities of
protein 4.1R are cell type-regulated. A major difference between T and
COS-7 cells is that T cells experiment internal protein rearrangements
during polarization in response to many stimuli (see below). Whether
some cell type-specific partners of 4.1R are required for specialized
4.1R roles remains to be established.
Polarization is a key feature in the biology of T cells, as T
lymphocytes acquire a polarized phenotype after activation, upon
interaction with antigen-presenting cells, and during transendothelial migration. To extravasate, circulating lymphocytes must adopt a
polarized flexible form suitable for tissue invasion. The anterior region of the polarized lymphocyte bears multiple, highly labile lamellipodia, whereas the posterior part is drawn out into a single slender appendage called the uropod (reviewed in Ref. 46). Polarization involves a reorganization of the cytoskeleton, including polymerization and redistribution of actin and a drastic reconfiguration of the tubulin cytoskeleton, which, in conjunction with the microtubule organizing center, retract into the uropod lumen, collapsing into a
thin, compact sheaf. Microtubule retraction has been suggested as being
a strategy for accelerating extravasation without disassembling the
microtubule-based transport system (47).
The distribution of spectrin has been analyzed during lymphocyte
activation, revealing a rapid reorganization of the protein, whereby
the initial aggregated cytoplasmic structures are translocated to
specific areas of the plasma membrane (48). Different distributions are
observed for proteins of the ERM family in T lymphocytes induced to
polarize by chemokines. Thus, radixin colocalizes with myosin II in the
neck of the uropod, whereas moesin is preferentially located at the
uropod tip, interacting with the cytoplasmic tail of ICAM-3, CD43, and
CD44 (49). Interactions between 4.1R and CD44 have also been reported
(28). Further studies will be conducted to determine the behavior of
4.1R during T cell polarization, which may provide new clues for
understanding the complex cytoskeletal reorganization experienced by
this cell type.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
4.1R135
16;
pCR3.1-4.1R135
16,19;
pCR3.1-4.1R135
4,5,16; pSR
4.1R80
16 and
pCR3.1-4.1R80
16,19), were isolated from MOLT-4 T cells
as described previously (18, 19, 35).
16,
GST-Cter and GST-core were constructed by polymerase chain reaction
using pSR
4.1R80
16 as template. For
GST-4.1R60
16,18, the template
pCR3.1-4.1R60
16,18 was used. Appropriate sense and
antisense primers containing the BglII and XhoI
restriction sites at the 5' and 3' ends, respectively, were used for
the amplification reactions. The amplified cDNAs were inserted into
the BamHI and XhoI sites of pGEX-6P1 vector (Amersham Pharmacia Biotech) in-frame with the GST coding sequence. The
GST-core
leu construct with a 66-nucleotide deletion (1403-1469) in
exon 10 (GenBankTM accession no. M61733) (22) was obtained by
polymerase chain reaction using the GST-core region construct as the
template and sense and antisense oligonucleotide primers annealing to
the flanking regions of the sequence to be deleted. All cDNA
constructs were sequenced as previously described (19). The GST fusion
proteins were overexpressed in Escherichia coli BL21 cells
and purified by glutathione affinity chromatography (Amersham Pharmacia
Biotech) using standard protocols. Subsequently the proteins were
dialyzed against CSF-XB buffer (10 mM K-Hepes, pH 7.7, 50 mM sucrose, 100 mM KCl, 2 mM
MgCl2, 0.1 mM CaCl2, and 5 mM EGTA) (36), frozen in liquid nitrogen, and stored at
70 °C.
-tubulin antibody DM1A was a monoclonal antibody obtained from
Sigma. Anti-GST antibody was a polyclonal antibody from Sigma.
Fluorescence- and horseradish peroxidase-labeled antibodies were
obtained from Southern Biotechnology Associates, Inc. (Birmingham, AL).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
16 and 4.1R80
16,19)
encode 4.1R isoforms that are translated from the ATG-2 translation
initiation codon present in exon 4 (Fig.
1B), whereas the other three
4.1R cDNAs (4.1R135
16, 4.1R135
16,19,
and 4.1R135
4,5,16) encode 4.1R isoforms that are
translated from the 5' upstream-ATG-1 translation initiation site (Fig.
1B). The only difference between the isoforms
4.1R135
16 and 4.1R135
16,19 and their
respective counterparts 4.1R80
16 and
4.1R80
16,19 is that the first two have the 209-amino
acid NH2-terminal extension. Fig. 3 shows confocal
microscopy images of Jurkat T cells transiently expressing the 4.1R
isoforms and double-stained with 10b (10b) and DM1A (DM1A) antibodies.
Antibody 10b was highly diluted to react only with the exogenously
expressed 4.1R isoforms but not with the endogenous 4.1R proteins. All
4.1R isoforms localized to cytoplasmic filaments (Fig. 3, A
(a, c, and e) and B
(a and c)) that were also stained by the
tubulin-recognizing monoclonal antibody DM1A (Fig. 3A
(b, d, and f) and B
(b and d)). The distribution of the exogenously
expressed 4.1R isoforms on the microtubule network resembled that of
the endogenous 4.1R proteins (compare Figs.
2 and
3).

View larger version (33K):
[in a new window]
Fig. 1.
Schematic representation of the exon map for
the 4.1R protein and the cDNA constructs used in this study.
A, schematic representation for 4.1R cDNA. Exons are coded
as follows: shaded, alternative; white,
constitutive; black, noncoding. The number of each
individual exon is represented at the bottom. Three
translation initiation sites at exons 2' (ATG-1), 4 (ATG-2), and 8 (ATG-3) are indicated, and the
stop codon (TGA) at exon 21. These data have been taken from
Refs. 16, 18, 20, 22, and 50-52. B, exon composition of the
T cell-4.1R cDNAs used for the T cell-transfection experiments. The
nucleotide sequence for c-Myc epitope tagging (myc) was
added at the 3' end of all cDNAs. C, GST fusion proteins
used for the identification of the 4.1R region involved in tubulin
association.

View larger version (51K):
[in a new window]
Fig. 2.
Colocalization of endogenous 4.1R with the
tubulin skeleton of T cells. A, CEM cells fixed with
formalin in the absence of Triton X-100 were double-labeled with the
anti-tubulin antibody DM1A (b and d) and the
anti-4.1R antibodies 10b (a) or 762 (c). Areas in
lower right (a-d) of each
panel show enlargements of indicated areas. B,
CEM cells fixed with formalin containing Triton X-100 were
double-labeled with a human anti-centrosome antibody (b and
d) and the anti-4.1R antibodies 10b (a) or 762 (c). The samples were analyzed by confocal microscopy.

View larger version (87K):
[in a new window]
Fig. 3.
Exogenously expressed 4.1R isoforms
colocalize with microtubules of T cells. Jurkat cells were
transfected with 4.1R cDNAs encoding either ATG1-translated 4.1R
isoforms (A) (4.1R135
16 (a and
b), 4.1R135
16,19 (c and
d), and 4.1R135
4,5,16 (e and
f)) or ATG2-translated 4.1R isoforms (B)
(4.1R80
16 (a and b) and
4.1R80
16,19 (c and d)). Cells were
double-labeled with antibodies 10b (10b) and DM1A
(DM1A) 48 h after transfection and examined by confocal
microscopy. Areas in lower right (a
and b) of each panel show enlargements of
indicated areas. Antibody 10b was used at dilutions that only detect
exogenous epitope-tagged 4.1R proteins.
16 or 4.1R80
16 cDNAs.
Taxol-polymerized microtubules were isolated from these cells by
centrifugation through a sucrose cushion, and the presence or absence
of the expressed 4.1R proteins in the pellet fractions was analyzed by
Western blot. Control cells, transfected with an empty plasmid, were
processed in parallel.
16 and 4.1R80
16 in
CEM cells was confirmed by Western blot analysis revealed with antibody
9E10 (Fig. 4A), as the
exogenous 4.1R isoforms were tagged at their COOH-terminal region with
the 9E10 c-Myc epitope to distinguish them from the endogenous 4.1R
proteins (19). Western blots of equivalent aliquots of microtubule
pellets and supernatants isolated from control and transfected cells
were revealed with 9E10 antibody (Fig. 4B). Isoforms
4.1R135
16 and 4.1R80
16 were present in
the microtubule pellets (Fig. 4B, lanes 3 and
5), suggesting their in vivo association with the
tubulin skeleton.

View larger version (20K):
[in a new window]
Fig. 4.
Endogenous and exogenous 4.1R proteins
cosediment with Taxol-polymerized microtubules of T cells.
A, Western blot of total lysates of CEM cells transfected
with an empty plasmid (Control) or CEM cells stably
expressing isoforms 4.1R80
16
(4.1R80
16) or
4.1R135
16
(4.1R135
16), revealed
with the 9E10 antibody, which recognizes exogenous 4.1R isoforms.
B, sedimentation of exogenous 4.1R proteins. Control CEM
cells (control), CEM cells stably expressing the
ATG2-translated isoform 4.1R80
16
(4.1R80
16) or the ATG1-translated
isoform 4.1R135
16
(4.1R135
16) were homogenized and
processed to isolate the Taxol-polymerized microtubule fraction, as
indicated under "Experimental Procedures." MT,
microtubule pellet obtained by centrifugation at 30,000 × g after Taxol addition; S, 30,000 × g supernatant. C, sedimentation of endogenous
4.1R proteins. Replicas of the microtubule pellet shown in lane
1 revealed with anti-4.1R 10b (10b) or 762 (762) antibodies to detect endogenous 4.1R immunoreactive
proteins cosedimenting with the microtubules.
16 could bind
directly to tubulin, the major component of microtubules, we prepared
tubulin depleted in microtubule-associated proteins (PC-tubulin) and
performed in vitro binding assays. Taxol-polymerized tubulin
was incubated with a GST fusion protein containing
4.1R80
16 (GST-4.1R80
16) and processed as
indicated under "Experimental Procedures." Protein
GST-4.1R80
16 was detected in the pellet fraction with
polymerized tubulin (Fig. 5A,
lane 1) but not in the supernatant fraction (Fig.
5A, lane 5). Similar results were confirmed by
the blot analysis (Fig. 5B, lanes 1 and
5).

View larger version (33K):
[in a new window]
Fig. 5.
In vitro association of protein
4.1R isoforms with tubulin. A and B,
Coomassie Blue-stained SDS gels (A) and Western blots
(B) revealed with anti-GST antibody of equivalent aliquots
of Taxol-polymerized tubulin (pellets) and supernatant fractions
(supernatants) obtained in in vitro binding assays performed
with PC-tubulin and the indicated GST fusion proteins. C,
Coomassie Blue-stained SDS gel of all purified GST fusion proteins used
in this study for the in vitro binding assays. The
composition of the GST fusion proteins is shown in Fig. 1C.
Note that the fusion protein GST-Cter remains unbound to tubulin
(lanes 7 and 8 in A and B)
whereas GST-4.1R80
16 and GST-4.1R60
16,18
remain in the pellet associated with PC-tubulin (lanes 1 and
2, respectively, in A and B).
16 region interacting with
tubulin, we fused various 4.1R fragments to GST (Fig.
1C) and assayed in vitro their ability to
associate with PC-tubulin. Fig. 5C shows a Coomassie-stained gel of the different GST fusion proteins used for the study. Protein GST-Cter (Fig. 5C, lane 3) contained the
carboxyl-terminal region of protein 4.1R80
16 (see Fig.
1C), and the GST-4.1R60
16,18 protein (Fig.
5C, lane 2) contained a short 4.1R isoform translated from the ATG3 triplet (18) whose sequence is comprised in
4.1R80
16 (see Fig. 1C). Fig. 5
(panels A (Coomassie-stained gels) and B (Western blots revealed with anti-GST)) shows that
GST-4.1R60
16,18 protein was detected in the tubulin
pellets (Fig. 5, A and B, lanes 2) but
not in the supernatants (Fig. 5, A and B, lanes 6). By contrast, protein GST-Cter, assayed at two
different concentrations, was observed in the supernatant fractions
(Fig. 5, A and B, lanes 7 and
8). The absence of GST-Cter protein from the tubulin pellets
was confirmed by Western blot analysis (Fig. 5B, lanes
3 and 4). The fact that GST-Cter did not bind to
tubulin, whereas the GST-4.1R60
16,18 and
GST-4.1R80
16 proteins did, suggested that the common
central region of the latter proteins, previously designated by us as
"the core region" (18), was responsible for their association with tubulin.
16 (Fig. 6, A and
B, lanes 1 and 4) and GST-Cter (Fig.
6, A and B, lanes 2 and 5)
were used as positive and negative controls, respectively. These
results confirmed that the core region, present in all 4.1R isoforms,
is responsible for tubulin binding.

View larger version (20K):
[in a new window]
Fig. 6.
Identification of the 4.1R region involved in
tubulin association. Coomassie Blue-stained SDS gel (A)
and Western blots revealed with anti-GST (B) of equivalent
aliquots of Taxol-polymerized tubulin (pellets) and supernatant
fractions (supernatants) from in vitro binding assays. Note
that the core region common to all protein 4.1R isoforms is involved in
tubulin association (lane 3 in A and
B). GST-4.1R80
16 and GST-Cter were used in
the assay as positive and negative controls, respectively.
leu, that lacked 22 amino
acids from the leucine zipper-resembling motif (amino acids
boxed in Fig. 7A), fused it to GST
(GST-core-
leu) (see Fig. 1C), and determined its
tubulin-binding capacity. As expected, GST-core was detected in the
pellet fraction (Fig. 7, B and C, lanes
1), whereas GST-core-
leu remained in the supernatant (Fig. 7,
B and C, lanes 4), indicating that the
22-amino acid stretch containing the heptad repeats of leucine is
essential for tubulin binding.

View larger version (25K):
[in a new window]
Fig. 7.
Twenty-two amino acids in the 4.1R core
region are required for tubulin interaction. A, amino
acid sequence containing four heptad repeats, resembling a leucine
zipper motif, in the core region of 4.1R. The leucine residues are
highlighted. The 22 boxed amino acids are deleted
in GST-core
leu. B and C, Coomassie
Blue-stained SDS gel (B) and Western blot (C)
revealed with anti-GST of equivalent aliquots of tubulin pellets
(P) and supernatants (S) from the in
vitro binding assays. Note that GST-core binds to tubulin
(B and C, lanes 1), whereas removal of
the heptad repeats of leucine (GST-core
leu) abolishes the
association (B and C, lanes 4).
16 in COS-7 Cells
Leads to Disruption of the Microtubule Architecture--
COS-7 cells
were transfected with 4.1R80
16 cDNA to compare the
distribution pattern of the expressed 4.1R isoform with that of tubulin
by double immunofluorescence microscopy (Fig.
8). Isoform 4.1R80
16 did
not result to colocalize with microtubules as it did in T cells but
instead led to disorganization of the microtubule network (compare Fig.
8 with Fig. 3B, a and b). Similar
disorganization of the microtubule architecture was also observed with
other 4.1R cDNAs assayed (data not shown). A representative image
of the altered microtubule network showing microtubules that no longer radiate from a single perinuclear focus is represented in Fig. 8.

View larger version (83K):
[in a new window]
Fig. 8.
Exogenous expression of 4.1R induces
microtubule disorganization in COS-7 cells. COS-7 cells were
transfected with a 4.1R cDNA encoding isoform
4.1R80
16 and processed for double immunofluorescence
with antibodies 10b (10b) and DM1A (DM1A) 48 h after transfection. Cells were analyzed by epifluorescence
microscopy. The white arrow indicates a
representative transfected cell presenting a disorganized microtubule
network, which is no longer well focused at the centrosome.
Untransfected cells show typical microtubules radiating from the
centrosome.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helix conformation (42). The crystal structure of
the NH2-terminal 30-kDa domain of 4.1R has been determined
and has the form of a three-lobed cloverleaf (43). The COOH-terminal
lobe contains two
-sheets and ends in an
-helix; one of the
-sheets contains the binding site for p55, a palmitoylated peripheral membrane protein belonging to a membrane-associated guanylate kinase homologue family of signaling and cytoskeletal proteins (7, 44). The 22 amino acids identified in this study as being
required for 4.1R-tubulin associations would be located on the other
-sheet of the COOH-terminal lobe. Removal of the 22 amino acids
would result in an almost complete absence of this
-sheet structure.
| |
ACKNOWLEDGEMENTS |
|---|
We are very grateful to Dr. Isabelle Vernos for invaluable help. We also thank Drs. Jesús Avila and Jorge Domínguez for providing us with PC-tubulin and anti-centrosome antibody, and Drs. Miguel A. Alonso, Jaime Millán, and Antonio Rodríguez for generous comments. We acknowledge Dr. Carlos Sánchez for assistance with confocal microscopy techniques.
| |
FOOTNOTES |
|---|
* This work was supported by Grant PM98-0002 from the Ministerio de Ciencia y Tecnología, Spain.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Predoctoral fellow of the Ministerio de Educación y Cultura, Spain.
§ Present address: European Molecular Biology Laboratory, D-69117 Heidelberg, Germany.
¶ To whom correspondence should be addressed. Fax: 34-91-397-8087; E-mail: icorreas@cbm.uam.es.
Published, JBC Papers in Press, September 28, 2001, DOI 10.1074/jbc.M107369200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GST, glutathione S-transferase; ERM, ezrin-radixin-moesin; Pipes, 1,4-piperazinediethanesulfonic acid; MES, 4-morpholineethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Conboy, J. G. (1993) Semin. Hematol. 30, 58-73 |
| 2. | Correas, I., Speicher, D. W., and Marchesi, V. T. (1986) J. Biol. Chem. 261, 13362-13366 |
| 3. | Correas, I., Leto, T. L., Speicher, D. W., and Marchesi, V. T. (1986) J. Biol. Chem. 261, 3310-3315 |
| 4. | Horne, W. C., Huang, S. C., Becker, P. S., Tang, T. K., and Benz, E. J., Jr. (1993) Blood 82, 2558-2563 |
| 5. | Schischmanoff, P. O., Winardi, R., Discher, D. E., Parra, M. K., Bicknese, S. E., Witkowska, H. E., Conboy, J. G., and Mohandas, N. (1995) J. Biol. Chem. 270, 21243-21250 |
| 6. | Delaunay, J. (1995) Crit. Rev. Oncol. Hematol. 19, 79-110 |
| 7. | Nunomura, W., Takakuwa, Y., Parra, M., Conboy, J. G., and Mohandas, N. (2000) J. Biol. Chem. 275, 6360-6367 |
| 8. | Anderson, R. A., Correas, I., Mazzucco, C., Castle, J. D., and Marchesi, V. T. (1988) J. Cell. Biochem. 37, 269-284 |
| 9. | Granger, B. L., and Lazarides, E. (1984) Cell 37, 595-607 |
| 10. | Cohen, C. M., Foley, S. F., and Korsgren, C. (1982) Nature 299, 648-650 |
| 11. | Krauss, S. W., Chasis, J. A., Rogers, C., Mohandas, N., Krockmalnic, G., and Penman, S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7297-7302 |
| 12. | Correas, I. (1991) Biochem. J. 279, 581-585 |
| 13. | De Cárcer, G., Lallena, M. J., and Correas, I. (1995) Biochem. J. 312, 871-877 |
| 14. | Krauss, S. W., Larabell, C. A., Lockett, S., Gascard, P., Penman, S., Mohandas, N., and Chasis, J. A. (1997) J. Cell Biol. 137, 275-289 |
| 15. | Lallena, M. J., and Correas, I. (1997) J. Cell Sci. 110, 239-247 |
| 16. | Gascard, P., Lee, G., Coulombel, L., Auffray, I., Lum, M., Parra, M., Conboy, J. G., Mohandas, N., and Chasis, J. A. (1998) Blood 92, 4404-4414 |
| 17. | Mattagajasingh, S. N., Huang, S. C., Hartenstein, J. S., Snyder, M., Marchesi, V. T., and Benz, E. J. (1999) J. Cell Biol. 145, 29-43 |
| 18. | Luque, C. M., and Correas, I. (2000) J. Cell Sci. 113, 2485-2495 |
| 19. | Luque, C. M., Lallena, M. J., Alonso, M. A., and Correas, I. (1998) J. Biol. Chem. 273, 11643-11649 |
| 20. | Tang, T. K., Leto, T. L., Correas, I., Alonso, M. A., Marchesi, V. T., and Benz, E. J., Jr. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3713-3717 |
| 21. | Tang, T. K., Qin, Z., Leto, T., Marchesi, V. T., and Benz, E. J., Jr. (1990) J. Cell Biol. 110, 617-624 |
| 22. | Conboy, J. G., Chan, J. Y., Chasis, J. A., Kan, Y. W., and Mohandas, N. (1991) J. Biol. Chem. 266, 8273-8280 |
| 23. | Conboy, J. G., Chan, J., Mohandas, N., and Kan, Y. W. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9062-9065 |
| 24. | Lallena, M. J., Martínez, C., Valcárcel, J., and Correas, I. (1998) J. Cell Sci. 111, 1963-1971 |
| 25. | Tang, C. J., and Tang, T. K. (1998) Blood 92, 1442-1447 |
| 26. | Pu, W. T., Krapivinsky, G. B., Krapivinsky, L., and Clapham, D. E. (1999) Mol. Cell. Biol. 19, 4113-4120 |
| 27. | Hung, L. Y., Tang, C. J., and Tang, T. K. (2000) Mol. Cell. Biol. 20, 7813-7825 |
| 28. | Nunomura, W., Takakuwa, Y., Tokimitsu, R., Krauss, S. W., Kawashima, M., and Mohandas, N. (1997) J. Biol. Chem. 272, 30322-30328 |
| 29. | Hou, C. L., Tang, C., Roffler, S. R., and Tang, T. K. (2000) Blood 96, 747-753 |
| 30. | Mattagajasingh, S. N., Huang, S. C., Hartenstein, J. S., and Benz, E. J., Jr. (2000) J. Biol. Chem. 275, 30573-30585 |
| 31. | Kontrogianni-Konstantopoulos, A., Frye, C. S., Benz, E. J., Jr., and Huang, S. C. (2001) J. Biol. Chem. 276, 20679-20687 |
| 32. | Pasternack, G. R., and Racusen, R. H. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 9712-9716 |
| 33. | Correas, I., and Avila, J. (1988) Biochem. J. 255, 217-221 |
| 34. | Kontrogianni-Konstantopoulos, A., Huang, S. C., and Benz, E. J., Jr. (2000) Mol. Biol. Cell 11, 3805-3817 |
| 35. | Luque, C. M., Lallena, M. J., Pérez-Ferreiro, C. M., de Isidro, Y., De Cárcer, G., Alonso, M. A., and Correas, I. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 14925-14930 |
| 36. | Wittmann, T., Boleti, H., Antony, C., Karsenti, E., and Vernos, I. (1998) J. Cell Biol. 143, 673-685 |
| 37. | Evan, G. I., Lewis, G. K., Ramsay, G., and Bishop, J. M. (1985) Mol. Cell. Biol. 5, 3610-3616 |
| 38. | Dominguez, J. E., Buendia, B., Lopez-Otin, C., Antony, C., Karsenti, E., and Avila, J. (1994) J. Cell Sci. 107, 601-611 |
| 39. | Laemmli, U. K. (1970) Nature 227, 680-685 |
| 40. | Charrasse, S., Schroeder, M., Gauthier-Rouviere, C., Ango, F., Cassimeris, L., Gard, D. L., and Larroque, C. (1998) J. Cell Sci. 111, 1371-1383 |
| 41. | Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., and Kirschner, M. W. (1975) Proc. Natl. Acad. Sci. U. S. A. 72, 1858-1862 |
| 42. | O'Shea, E. K., Rutkowski, R., and Kim, P. S. (1989) Science 243, 538-542 |
| 43. | Han, B. G., Nunomura, W., Takakuwa, Y., Mohandas, N., and Jap, B. K. (2000) Nat. Struct. Biol. 7, 871-875 |
| 44. | Marfatia, S. M., Leu, R. A., Branton, D., and Chishti, A. H. (1995) J. Biol. Chem. 270, 715-719 |
| 45. | Bretscher, A. (1999) Curr. Opin. Cell Biol. 11, 109-116 |
| 46. | Sanchez-Madrid, F., and del Pozo, M. A. (1999) EMBO J. 18, 501-511 |
| 47. | Ratner, S., Sherrod, W. S., and Lichlyter, D. (1997) J. Immunol. 159, 1063-1067 |
| 48. | Lee, J. K., Black, J. D., Repasky, E. A., Kubo, R. T., and Bankert, R. B. (1988) Cell 55, 807-816 |
| 49. | Serrador, J. M., Alonso-Lebrero, J. L., del Pozo, M. A., Furthmayr, H., Schwartz-Albiez, R., Calvo, J., Lozano, F., and Sanchez-Madrid, F. (1997) J. Cell Biol. 138, 1409-1423 |
| 50. | Huang, J. P., Tang, C. J., Kou, G. H., Marchesi, V. T., Benz, E. J., Jr., and Tang, T. K. (1993) J. Biol. Chem. 268, 3758-3766 |
| 51. | Schischmanoff, P. O., Yaswen, P., Parra, M. K., Lee, G., Chasis, J. A., Mohandas, N., and Conboy, J. G. (1997) J. Biol. Chem. 272, 10254-10259 |
| 52. | Baklouti, F., Huang, S. C., Vulliamy, T. J., Delaunay, J., and Benz, E. J., Jr. (1997) Genomics 39, 289-302 |
This article has been cited by other articles:
![]() |
S. W. Krauss, J. R. Spence, S. Bahmanyar, A. I. M. Barth, M. M. Go, D. Czerwinski, and A. J. Meyer Downregulation of Protein 4.1R, a Mature Centriole Protein, Disrupts Centrosomes, Alters Cell Cycle Progression, and Perturbs Mitotic Spindles and Anaphase Mol. Cell. Biol., April 1, 2008; 28(7): 2283 - 2294. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mburu, Y. Kikkawa, S. Townsend, R. Romero, H. Yonekawa, and S. D. M. Brown Whirlin complexes with p55 at the stereocilia tip during hair cell development PNAS, July 18, 2006; 103(29): 10973 - 10978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Huang, E. S. Liu, S.-H. Chan, I. D. Munagala, H. T. Cho, R. Jagadeeswaran, and E. J. Benz Jr Mitotic Regulation of Protein 4.1R Involves Phosphorylation by cdc2 Kinase Mol. Biol. Cell, January 1, 2005; 16(1): 117 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Perez-Ferreiro, I. Vernos, and I. Correas Protein 4.1R regulates interphase microtubule organization at the centrosome J. Cell Sci., December 1, 2004; 117(25): 6197 - 6206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Huang, R. Jagadeeswaran, E. S. Liu, and E. J. Benz Jr. Protein 4.1R, a Microtubule-associated Protein Involved in Microtubule Aster Assembly in Mammalian Mitotic Extract J. Biol. Chem., August 13, 2004; 279(33): 34595 - 34602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Krauss, G. Lee, J. A. Chasis, N. Mohandas, and R. Heald Two Protein 4.1 Domains Essential for Mitotic Spindle and Aster Microtubule Dynamics and Organization in Vitro J. Biol. Chem., June 25, 2004; 279(26): 27591 - 27598. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Hung, H.-L. Chen, C.-W. Chang, B.-R. Li, and T. K. Tang Identification of a Novel Microtubule-destabilizing Motif in CPAP That Binds to Tubulin Heterodimers and Inhibits Microtubule Assembly Mol. Biol. Cell, June 1, 2004; 15(6): 2697 - 2706. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Luque, C. M. Perez-Ferreiro, A. Perez-Gonzalez, L. Englmeier, M. D. Koffa, and I. Correas An Alternative Domain Containing a Leucine-rich Sequence Regulates Nuclear Cytoplasmic Localization of Protein 4.1R J. Biol. Chem., January 17, 2003; 278(4): 2686 - 2691. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||